0001213900-23-081834.txt : 20231031 0001213900-23-081834.hdr.sgml : 20231031 20231031163026 ACCESSION NUMBER: 0001213900-23-081834 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 EFFECTIVENESS DATE: 20231031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PURPLE BIOTECH LTD. CENTRAL INDEX KEY: 0001614744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496202 FILM NUMBER: 231365109 BUSINESS ADDRESS: STREET 1: 4 OPPENHEIMER STREET STREET 2: SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 7670104 BUSINESS PHONE: 97239333121 MAIL ADDRESS: STREET 1: 4 OPPENHEIMER STREET STREET 2: SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 7670104 FORMER COMPANY: FORMER CONFORMED NAME: Kitov Pharma Ltd. DATE OF NAME CHANGE: 20180125 FORMER COMPANY: FORMER CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd. DATE OF NAME CHANGE: 20140724 D 1 primary_doc.xml X0708 D LIVE 0001614744 PURPLE BIOTECH LTD. 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 ISRAEL 7670104 +972-3-933-3121 ISRAEL None Kitov Pharma Ltd. Kitov Pharmaceuticals Holdings Ltd. Corporation true Gil Efron 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Chief Executive Officer Lior Fhima 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Chief Financial Officer Eric Rowinsky 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Chairman of the Board of Directors Isaac Israel 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Simcha Rock 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Ido Agmon 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Robert Gagnon 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Suzana Nahum-Zilberberg 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Ori Hershkovitz 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Director Hadas Reuveni 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President of Research and Development Michael Schickler 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Head of Regulatory and Clinical Operations Ido Morpurgo 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President of Operations Fabien Sebille 4 Oppenheimer Street Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Chief Business Officer Biotechnology No Revenues 06b false 2023-10-17 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NEW YORK NY NEW YORK 10022 NY NEW YORK false 5434784 5434784 0 This Form D is being filed in connection with the issuance of warrants to purchase up to 4,347,827 ADSs at an exercise price of $1.25 per ADS, with each ADS representing 10 ordinary shares, no par value per share, of the Company. true 0 1 350000 0 The placement agent also received a 1% management fee and warrants to purchase 304,348 ADSs at an exercise price of $1.4375 per ADS, each representing 10 ordinary shares, no par value per share, of the Company. 0 false PURPLE BIOTECH LTD. /s/ Lior Fhima Lior Fhima Chief Financial Officer 2023-10-31